Evaluation of the prostate-specific antigen/solvent interaction analysis (PSA/SIA) assay for prostate cancer (CaP) diagnosis.

Abstract

5053 Background: We describe the clinical performance of a novel protein structural assay for prostate cancer (CaP) diagnosis. The assay uses Solvent Interaction Analysis (SIA) to accurately detect changes in PSA isoform composition that differentiate benign and malignant disease, independent of total serum PSA (tPSA). METHODS From January 2007 to… (More)

Topics

Cite this paper

@article{Vourganti2009EvaluationOT, title={Evaluation of the prostate-specific antigen/solvent interaction analysis (PSA/SIA) assay for prostate cancer (CaP) diagnosis.}, author={Srinivas Vourganti and Mark D Stovsky and Lee Ponsky and Michael B Siroky and Victor Kipnis and Olga Fedotoff and Larissa M Mikheeva and B Y Zaslavsky and Abderahmane Chait and J. Shawn Jones}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2009}, volume={27 15_suppl}, pages={5053} }